Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$10,952,456
+$918,928 QoQ
Shares Held
43,125
+5.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.01%
of 13F equity value
Holder Rank
#1,059
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRANSCEND CAPITAL ADVISORS, LLC holds $69,576,548 across 11 Drug Manufacturers - General names. JNJ ranks #2 (15.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
262,453 | $33,725,210 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
43,125 | $10,952,456 | |
| 3 | LLY |
ELI LILLY & Co
|
6,902 | $8,278,466 | |
| 4 | ABBV |
AbbVie Inc.
|
29,656 | $7,462,635 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
55,185 | $3,179,759 | |
| 6 | AMGN |
Amgen Inc
|
4,077 | $1,476,363 | |
| 7 | NVS |
Novartis AG
|
8,348 | $1,308,298 | |
| 8 | AZN |
Astrazeneca PLC
|
6,659 | $1,262,679 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,952,456 | 43,125 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $10,033,528 | 41,047 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $9,089,244 | 43,920 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $10,268,188 | 55,378 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $8,991,476 | 58,864 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $9,894,677 | 59,664 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $8,278,338 | 57,242 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $10,387,883 | 64,099 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $10,697,888 | 73,193 | Shares | Sole | 2024-07-02 | |
| 2024-03-31 | $16,316,191 | 103,143 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $16,273,060 | 103,822 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $17,543,057 | 112,636 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $8,595,784 | 51,932 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $9,243,115 | 59,633 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $9,751,786 | 55,204 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $8,717,706 | 53,365 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $9,438,384 | 53,171 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $9,045,996 | 51,041 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $8,918,734 | 52,135 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $7,795,443 | 48,269 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $8,107,184 | 49,212 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,709,753 | 40,826 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $6,522,141 | 41,442 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,408,634 | 29,612 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,529,531 | 25,098 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $3,761,464 | 28,685 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||